Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-063035

Director sold 3,000 shares at an average $71.26 ($213,780)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Waddill William D. Director 2020-12-10 Sale −1,200 $68.50 $82,200 26,800 D
Waddill William D. Director 2020-12-10 Sale −1,800 $73.10 $131,580 25,000 D
Open-market sales · 3,000 sh · avg $71.26 · $213,780
Loading xslF345X03/doc4.xml…